The Board of Directors of Hubei Hongyuan Pharmaceutical Technology Co., Ltd. has authorized a buyback plan on March 13, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.22 CNY | -1.17% | -4.28% | -41.42% |
1st Jan change | Capi. | |
---|---|---|
-41.42% | 85Cr | |
+38.59% | 73TCr | |
-7.89% | 35TCr | |
+15.66% | 33TCr | |
+0.24% | 28TCr | |
+13.47% | 24TCr | |
+7.35% | 21TCr | |
-6.42% | 20TCr | |
+4.23% | 16TCr | |
-1.70% | 16TCr |
- Stock Market
- Equities
- 301246 Stock
- News Hubei Hongyuan Pharmaceutical Technology Co., Ltd.
- Hubei Hongyuan Pharmaceutical Technology Co., Ltd. authorizes a Buyback Plan.